Cytochrome P-450 as a target for therapeutic inhibitors.
Mason
J I
JI
Department of Biochemistry, University of Texas Southwestern Medical Center at Dallas 75235-9051.
D000446:Aldehyde-Lyases / Q000037:antagonists & inhibitors; D000818:Animals; D000963:Antimetabolites / Q000633:toxicity*; D000964:Antimetabolites, Antineoplastic / Q000633:toxicity*; D047072:Aromatase Inhibitors; D002460:Cell Line; D065607:Cytochrome P-450 Enzyme Inhibitors; D005260:Female; D006801:Humans; D008297:Male; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D013254:Steroid 17-alpha-Hydroxylase; D014407:Tumor Cells, Cultured
D000963:Antimetabolites; D000964:Antimetabolites, Antineoplastic; D047072:Aromatase Inhibitors; D065607:Cytochrome P-450 Enzyme Inhibitors; D006899:Mixed Function Oxygenases; D013254:Steroid 17-alpha-Hydroxylase; D000446:Aldehyde-Lyases